GERD, or Gastroesophageal Reflux Disease, is a chronic digestive disorder where stomach acid or bile flows back into the esophagus, irritating its lining.
Ranked by community outcomes, then evidence grade, Health Voice mentions, and recency.
Why it may help GERD: Eases reflux symptoms
Why it may help GERD: Soothes esophageal lining
Why it may help GERD: Melatonin may reduce GERD symptoms by strengthening the lower esophageal sphincter and exerting anti-inflammatory and antioxidant effects on the esophageal mucosa.
Why it may help GERD: L-Glutamine supports the integrity of the intestinal barrier, which may reduce inflammation and improve gut function, potentially alleviating symptoms associated with GERD.
Why it may help GERD: Digestive enzymes can improve the breakdown of food, potentially reducing gastric distension and pressure on the lower esophageal sphincter, thereby alleviating GERD symptoms.
Why it may help GERD: DGL Licorice stimulates the production of protective mucus and promotes the healing of the esophageal lining, which can help alleviate symptoms of GERD.
Why it may help GERD: Fennel may help GERD by relaxing the smooth muscles of the gastrointestinal tract, potentially reducing spasms and improving digestion, which can alleviate reflux symptoms.
Why it may help GERD: Zinc Carnosine supports the integrity of the gastric and esophageal mucosa, promoting healing and strengthening the barrier against acid reflux in GERD.
Why it may help GERD: Often low in long-term PPI users
Why it may help GERD: Slippery Elm forms a protective mucilaginous layer on the esophageal lining, which can soothe irritation and reduce symptoms associated with GERD by creating a physical barrier.
Stomach acid support for low gastric acid and protein digestion.
Why it may help GERD: Marshmallow Root forms a protective mucilaginous layer on irritated mucous membranes, which can soothe the esophageal lining and reduce symptoms of GERD.
Why it may help GERD: Supports LES function
Why it may help GERD: Calms upper GI
Why it may help GERD: Use cautiously; can worsen LES
Why it may help GERD: Reduces reflux symptoms
Why it may help GERD: May help low-acid reflux
Why it may help GERD: Aloe Vera Juice can reduce inflammation and irritation of the esophageal lining, providing a soothing effect that may alleviate symptoms associated with GERD.
Community outcomes
Self-reported by community members · not medical advice.
Self-reported community outcomes. Not medical advice. Requires at least three reports per remedy to surface.
Community outcome data is still being collected for this ailment.
Be the first to share your experience →As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.
Structured experience reports from people managing this condition. Not medical advice.
You can share without an account — we'll send a one-time code to verify your email. Or sign in.
Loading posts…
Community Discussions
How global health authorities view GERD.
The Mayo Clinic emphasizes lifestyle and dietary changes as primary interventions for GERD. The NIH acknowledges that some complementary health approaches, such as herbal remedies, are used by individuals with GERD but notes that scientific evidence for their effectiveness is often limited or inconclusive. The NHS recommends lifestyle modifications as a first-line treatment. While some traditional remedies are used, major bodies generally advise consulting a healthcare provider before using supplements, especially if taking conventional medications.
Indexed studies for GERD, grouped by source type and quality.
Filter by source type
Pooled analyses across multiple human trials.
Koo TH, Fass R · Esophagus : official journal of the Japan Esophageal Society · 2026
Potassium-competitive acid blockers (PCABs), a new class of potent and sustained acid-suppressing drugs, have emerged as an alternative to proton pump inhibitors (PPIs) for gastroesophageal reflux disease (GERD) management. However, the specific benefits of PCABs for nocturnal GERD symptoms remain unclear. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of PCAB therapy compared with PPIs or placebo for managing nighttime heartburn and related symptoms in adults with GERD. We systematically searched the MEDLINE, EMBASE, and Cochrane CENTRAL databases from inception to August 8, 2024. We included randomized controlled trials (RCTs) that compared any PCAB (vonoprazan, tegoprazan, or fexuprazan) with either a PPI or placebo in adult GERD patients. The primary outcome was the proportion of patients with complete resolution of nighttime heartburn throughout the treatment period; the secondary outcome was the treatment-emergent adverse events (TEAEs). Meta-a
King E, Horn D, Gluchowski N, O'Reilly D, Bruschettini M, Cooper C · The Cochrane database of systematic reviews · 2025 · n=52
Although physiological reflux is seen in nearly all newborns to varying degrees, symptoms can be severe and cause gastroesophageal reflux disease (GERD). In preterm infants, one symptom that is often attributed to GERD is apnea and associated cardiorespiratory events, such as bradycardia and oxygen desaturation. Although the relationship between GERD and apnea, bradycardia, and desaturation events remains a subject of ongoing investigation, trials of agents that reduce gastric acidity, such as proton pump inhibitors (PPI), have been conducted to assess the effect of these agents on GERD. To assess the benefits and harms of PPIs for the treatment of preterm infants with diagnosed or suspected GERD. We searched CENTRAL, MEDLINE, Embase, two trial registries, and Epistemonikos in October 2023. We checked reference lists of included studies, and studies and systematic reviews in which the subject matter was related to the intervention or population examined in this review. We included r
Yu C, Wang T, Gao Y, Jiao Y, Jiang H, Bian Y · Journal of sport and health science · 2024 · n=850
Lifestyle plays an important role in preventing and managing gastroesophageal reflux disease (GERD). In response to the conflicting results in previous studies, we performed a systematic review and meta-analysis to investigate this association. Relevant studies published until January 2023 were retrieved from 6 databases, and the prevalence of symptomatic gastroesophageal reflux (GER) or GERD was determined from the original studies. A random effects model was employed to meta-analyze the association by computing the pooled relative risk (RR) with 95% confidence intervals (95%CIs). Furthermore, subgroup and dose-response analyses were performed to explore subgroup differences and the association between cumulative physical activity (PA) time and GERD. This meta-analysis included 33 studies comprising 242,850 participants. A significant negative association was observed between PA and the prevalence of symptomatic GER (RR = 0.74, 95%CI: 0.66-0.83; p < 0.01) or GERD (R
Structured reviews of the full body of evidence (incl. Cochrane).
Ciomperlik H, Dhanani NH, Mohr C, Hannon C, Olavarria OA, Holihan JL · Journal of the American College of Surgeons · 2023
The aim of this systematic review is to assess all comparative randomized controlled trials evaluating Heller myotomy, pneumatic dilation, and peroral endoscopic myotomy. Achalasia is an esophageal motility disorder associated with degeneration of the myenteric plexus; it causes significant symptoms and impacts patient quality of life (QOL). The optimal treatment for patients with achalasia and the impact of these interventions on QOL remain unclear. PubMed, Embase, Scopus, and Cochrane were searched from inception to April 2020. Randomized controlled trials that compared the 3 interventions were included. Primary outcome was QOL at 12 to 36 months after the operation. Secondary outcomes included reintervention, dysphagia, leak/perforation, and GERD recurrence. Nine publications of 6 studies were included. Of the 9 publications, there was no significant difference in QOL at 12 to 36 months except for one study in which QOL was significantly higher in patients who underwent Heller myo
Schuitenmaker JM, Kuipers T, Smout AJPM, Fockens P, Bredenoord AJ · Neurogastroenterology and motility · 2022
Nocturnal gastroesophageal reflux symptoms have a major impact on sleep quality and are associated with complicated gastroesophageal reflux disease (GERD). We performed a systematic review to assess the data on the effectiveness of the currently available interventions for the treatment of nocturnal reflux symptoms. We searched PubMed, EMBASE, and the Cochrane Library. All prospective, controlled, and uncontrolled clinical trials in adult patients describing interventions (lifestyle modifications, surgical and pharmacological) for nocturnal gastroesophageal reflux symptoms were assessed for eligibility. A narrative descriptive summary of findings is presented together with summary tables for study characteristics and quality assessment. The initial reference search yielded 3067 citations; 66 citations were screened in full text, of which 31 articles were included. Studies on lifestyle modifications include head of bed elevation (n = 5), prolonging dinner-to-bed time (n 
Dietary and Lifestyle Factors Related to Gastroesophageal Reflux Disease: A Systematic Review.
Zhang M, Hou ZK, Huang ZB, Chen XL, Liu FB · Therapeutics and clinical risk management · 2021
We performed this review to clarify which dietary and lifestyle factors are related to gastroesophageal reflux disease. Through a systematic search of the PubMed, EMBASE, China National Knowledge Infrastructure (CNKI), and Chinese BioMedical Literature (CBM) databases, we identified articles with clear definitions of GERD, including nonerosive gastroesophageal reflux disease (NERD), reflux esophagitis (RE) and Barrett's esophagus (BE), that included dietary and lifestyle factors as independent factors affecting the onset of GERD (expressed as odds ratios (ORs) or relative risks (RRs) and 95% confidence intervals (CIs)). Due to heterogeneity among the studies, we used descriptive statistical analyses to analyze and synthesize each outcome based on the disease type. In total, 72 articles were included, conducted in ten Western countries (26 articles in total) and nine Eastern countries (46 articles in total). We categorized dietary factors into 20 items and lifestyle factors into 11 item
Recommendations from medical societies (NICE, AHA, ADA, ACG, Endocrine Society…).
American College of Gastroenterology (ACG)
The ACG provides various clinical guidelines for gastrointestinal disorders, including GERD. These guidelines offer evidence-based recommendations for diagnosis and management to healthcare professionals.
Controlled human studies with random assignment.
Effect of Fermented Soybean (FSB) Supplementation on Gastroesophageal Reflux Disease (GERD).
Tan ESS, Zaman R, Memon MA, Tan CK · Nutrients · 2024
Gastroesophageal reflux disease (GERD) is a prevalent chronic condition affecting the well-being of both adults and children in general medical practice. Research on the effects of fermented soybean (SB) supplementation in managing GERD is relatively new, with limited studies available. The existing research often lacks sufficient dosing regimens and study durations to differentiate between transient placebo effects and sustained benefits. In this study, the beneficial effects of FSB supplementation were investigated in 110 voluntary participants (NCT06524271). The participants were required to take 1 g of FSB supplement once daily for 12 weeks. GERD symptoms were evaluated using the Reflux Disease Questionnaire (RDQ), while inflammatory markers, including interleukin-4 (IL-4), interleukin-6 (IL-6), and interleukin-8 (IL-8), were measured to assess inflammation. The Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire was used to evaluate participants' quality of life. The re
Gu C, Olszewski T, King KL, Vaezi MF, Niswender KD, Silver HJ · The American journal of gastroenterology · 2022
This is the first randomized controlled diet intervention trial to investigate both the amount and type of carbohydrate on symptomatic gastroesophageal reflux disease (GERD). Ninety-eight veterans with symptomatic GERD were randomly assigned to high total/high simple, high total/low simple, low total/high simple, or low total/low simple carbohydrate diet for 9 weeks. The primary outcomes were esophageal acid exposure time (AET) and total number of reflux episodes derived from 24-hour ambulatory pH monitoring. Secondary outcomes were esophageal reflux symptoms rated using the Gastroesophageal Reflux Disease Questionnaire (GERDQ) and GERD Symptom Assessment Scale (GSAS). Half of the subjects were White and half African American (mean age, 60.0 ± 12.5 years; mean body mass index, 32.7 ± 5.4 kg/m 2 ). There was a significant main effect of diet treatment on AET ( P = 0.001) and on the total number of reflux episodes ( P = 0.003). The change in AET in the high total/low simple g
Zhang B, Hu Y, Shi X, Li W, Zeng X, Liu F · The American journal of gastroenterology · 2021
Impaired esophageal and gastric motilities are known to contribute to symptoms of gastroesophageal reflux disease (GERD). However, there is a lack of GERD therapy, targeting both gastric and esophageal functions. This study was designed to investigate the effects of transcutaneous electrical acustimulation (TEA) on symptoms of GERD and gastroesophageal functions and possible mechanisms in patients with GERD. Thirty patients with GERD with ineffective esophageal motility were equally divided and randomized into a 4-week sham-TEA or 4-week TEA treatment. The GERD questionnaire (GerdQ), GERD health-related quality-of-life questionnaire, high-resolution esophageal manometry, a nutrient drink test, the electrogastrogram, and ECG were performed to assess the severity of reflux symptoms, low esophageal sphincter (LES) pressure, distal contractile integral (DCI), gastric accommodation, gastric slow waves (GSW), and autonomic functions, respectively. Compared with sham-TEA, the 4-week TEA tre
Cohort, case-control, and cross-sectional human studies.
Nabi Z, Dhar J, Samanta J, Inavolu P, Puri R, Reddy DN · Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026 · n=419
Peroral endoscopic myotomy (POEM) is an established treatment for achalasia. Conventionally, esophageal myotomy of 6-10 cm length is performed, although its necessity in type-I and type-II achalasia remains debatable. Recent studies suggest that a shorter myotomy may offer similar efficacy with potential advantages. We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing short vs. standard (long) esophageal myotomy during POEM in patients with type-I and type-II achalasia. This review was conducted in accordance with PRISMA 2020 guidelines and registered with PROSPERO (CRD42024611252). A systematic search of PubMed, Embase and Scopus was performed to identify RCTs comparing short and long esophageal myotomy during POEM. The primary outcome was clinical success at ≥ 1 year (Eckardt score ≤ 3). Secondary outcomes included procedure time, adverse events, post-POEM integrated relaxation pressur
Mancuso T, Di Rosa C, Falcone A, Restaneo L, Citterio N, Biasutto D · Nutrients · 2025
Obesity is a multifactorial disease linked to chronic inflammation, metabolic disorders, and gut microbiota dysbiosis. Bariatric surgery (BS) and endoscopic sleeve gastroplasty (ESG) are effective for sustained weight loss and comorbidity improvement but may cause gastrointestinal and nutritional complications. This narrative review, informed by a structured literature search, synthesizes evidence on gastrointestinal side effects, gut microbiota alterations, and nutritional management after BS and ESG. Literature searches in PubMed and Scopus, without time limits, included English full-text articles on postoperative symptoms, microbiota changes, and nutritional outcomes. Bariatric procedures (e.g., Roux-en-Y gastric bypass, sleeve gastrectomy) and ESG are associated with adverse events such as dumping syndrome, GERD, nausea, and micronutrient deficiencies. Surgery induces profound shifts in gut microbiota composition and diversity, contributing to improved metabolic regulation. ESG, th
Scarpignato C, De Bortoli N, Iovino P, Nacci A, Sarnelli G, Savarino EV · Therapeutic advances in gastroenterology · 2025
Gastroesophageal reflux disease (GERD) remains a challenging condition, even in the third millennium. For much of the past century, Schwartz's dictum-"No acid, no ulcer"-has shaped our approach to acid-related diseases, making acid suppression the cornerstone of therapy. Proton pump inhibitors (PPIs) are widely regarded as the standard treatment for GERD. However, they provide only symptomatic relief and do not address the underlying disease. Moreover, nearly 50% of patients experience limited or no response to PPIs in clinical practice. Recent advances in understanding GERD's pathophysiology, particularly the role of impaired mucosal integrity, have led to innovative therapeutic strategies. Among these, medical devices designed to prevent reflux or coat the esophageal mucosa and form a stable protective barrier represent a significant breakthrough. Esophageal mucosal protection is emerging as a promising approach, especially for patients who do not respond adequately to PPIs. While mu
Preclinical animal research — not a substitute for human evidence.
Ex vivo evaluation of adhesive strength and barrier effect of a novel treatment for esophagitis.
Brito-Casillas Y, Caballero MJ, Hernández-Baraza L, Sánchez-Hernández RM, Betancort-Acosta JC, Wägner AM · Gastroenterologia y hepatologia · 2023
To investigate the mucoadhesive strength and barrier effect of Esophacare® (Atika Pharma SL, Las Palmas de Gran Canaria) in an ex vivo model of gastro-oesophageal reflux. An ex vivo evaluation through the Falling Liquide Film Technique with porcine esophagi was performed, compared to a positive control (Ziverel®; Norgine, Amsterdam), after different washing periods with saline, acidified saline (pH 1.2) and acidified saline with pepsin (2000U/mL). The adhesive mean strength on the oesophageal mucosa of Esophacare was 94.7 (6.0)%, compared to 27.6 (19.1)% of the positive control (p<0.05). These results were homogeneous across the different washes and throughout the tissue. The area covered by 1mL of Esophacare, and its respective persistence after washing was also assessed, yielding a mean global persistence of 74.29 (19.7)% vs. 18.9 (12.3)% for the control (p<0.05). In addition, after 30min exposure to acidified saline with pepsin, Esophacare shows a protective effect
Public-health agencies: NCCIH, NIH, CDC, NHS.
Indigestion - Causes, symptoms and treatments
NHS
This NHS page provides accessible information on indigestion, including its causes, common symptoms like heartburn and GERD, and various treatment approaches. It also offers advice on self-help measures.
Registered ongoing or completed trials (ClinicalTrials.gov).
n=1400 · NCT00206245 · COMPLETED · COMPLETED
The primary objective is to compare the efficacy between three doses of AZD0865 (25, 50 and 75 mg). The secondary objectives are to compare the efficacy between the three doses of AZD0865 and esomeprazole 40 mg and to evaluate the safety and tolerability of AZD0865.
Curated cross-source summaries (TRIP Database and similar).
Cochrane Library: Gastro-oesophageal reflux disease
Cochrane
The Cochrane Library provides a collection of systematic reviews and meta-analyses related to gastro-oesophageal reflux disease. It synthesizes high-quality evidence to inform healthcare decisions and practices.
Conventional medical treatment for GERD often includes antacids for temporary relief, H2 blockers to reduce acid production, and proton pump inhibitors (PPIs) to block acid production and allow esophageal healing. In some cases, surgery may be considered for severe GERD that doesn't respond to other treatments.
Latest News
Health Videos
This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before making any decisions about your health or treatment, especially if you have GERD or are considering new interventions.
Found something that helped your gerd?
Help others see what actually works.
Found something that helped your gerd?
Real-world results help others choose what's worth trying.